Cigna Corp
NYSE:CI
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
265.59
366.85
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Cigna Corp
Wall Street
Price Targets
CI Price Targets Summary
Cigna Corp
According to Wall Street analysts, the average 1-year price target for
CI
is 401.86 USD
with a low forecast of 348.23 USD and a high forecast of 441 USD.
CI Last Price Targets
Cigna Corp
The latest public price target was made on Jun 25, 2024 by
Jessica Tassan
from
Piper Sandler
,
who expects
CI
stock to
rise by 42%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Jessica Tassan
Piper Sandler
|
400
USD
Upside 42% |
6 months ago
Jun 25, 2024
|
Piper Sandler Starts CIGNA (CI) at Overweight
StreetInsider
|
Michael Ha
Robert W. Baird
|
388
USD
Upside 38% |
6 months ago
May 29, 2024
|
Cigna initiated with an Outperform at Baird
TheFly
|
David Windley
Jefferies
|
407
USD
Upside 45% |
7 months ago
May 6, 2024
|
CIGNA (CI) PT Raised to $407 at Jefferies
StreetInsider
|
Michael Wiederhorn
Oppenheimer
|
400
USD
Upside 42% |
7 months ago
May 3, 2024
|
CIGNA (CI) PT Raised to $400 at Oppenheimer
StreetInsider
|
Ben Hendrix
RBC Capital
|
384
USD
Upside 36% |
7 months ago
May 3, 2024
|
CIGNA (CI) PT Raised to $384 at RBC Capital
StreetInsider
|
Sarah James
Raymond James
|
400
USD
Upside 42% |
7 months ago
May 3, 2024
|
CIGNA (CI) PT Raised to $400 at Cantor Fitzgerald
StreetInsider
|
|
Ben Hendrix
RBC Capital
|
354
USD
Upside 26% |
10 months ago
Feb 5, 2024
|
Cigna 'Top Pick for 2024': Analysts Change Ratings, Forecasts Following 2024 Guidance
Benzinga
|
Ann Hynes
Mizuho Securities
|
370
USD
Upside 31% |
10 months ago
Feb 5, 2024
|
Cigna 'Top Pick for 2024': Analysts Change Ratings, Forecasts Following 2024 Guidance
Benzinga
|
|
Sarah James
Raymond James
|
372
USD
Upside 32% |
10 months ago
Feb 5, 2024
|
Cigna 'Top Pick for 2024': Analysts Change Ratings, Forecasts Following 2024 Guidance
Benzinga
|
|
Unknown Analyst
Leerink Partners
|
335
USD
Upside 19% |
1 year ago
Feb 8, 2023
|
SVB Leerink Maintains Market Perform on Cigna, Raises Price Target to $335
Benzinga
|
|
Unknown Analyst
Raymond James
|
350
USD
Upside 24% |
1 year ago
Feb 7, 2023
|
Raymond James Maintains Outperform on Cigna, Lowers Price Target to $350
Benzinga
|
|
Unknown Analyst
Stephens
|
370
USD
Upside 31% |
1 year ago
Feb 6, 2023
|
Stephens & Co. Maintains Overweight on Cigna, Lowers Price Target to $370
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CI's stock price target?
Price Target
401.86
USD
According to Wall Street analysts, the average 1-year price target for
CI
is 401.86 USD
with a low forecast of 348.23 USD and a high forecast of 441 USD.
What is Cigna Corp's Revenue forecast?
Projected CAGR
10%
For the last 8 years the
compound annual growth rate for
Cigna Corp's revenue is
23%.
The projected
CAGR
for the next 4 years is
10%.
What is Cigna Corp's Net Income forecast?
Projected CAGR
21%
For the last 8 years the
compound annual growth rate for
Cigna Corp's net income is
12%.
The projected
CAGR
for the next 4 years is
21%.
You don't have any saved screeners yet
